Create a Report
Please provide report title
Please provide location
Please provide details
Get alerts and updates for your case! Your contact information is not shown on the website.
This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.
Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Please accept our Terms & Conditions
Add photos or video
We recommend photos and videos to help explain your report
Add Photo/Video
Email or SMS copy of report
Enter below to get emailed a copy of your report, or sms a link to your report
Please provide email or phone
Please provide email or phone
Please accept our Terms & Conditions
Thank you for your report!


IMPORTANT - Your report is queued
It may take up to 12 hours to process your report.


Email us at support@safelyhq.com if you have questions.

Report by
Loading...
Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

Drug use, South Amherst, OH, USA

1 month ago

South Amherst, Ohio, United States

Heavy marijuana use in the apartment beneath me

1.2K


RK
anonymous10021
Call the police to report it then,
Reply 3 weeks ago

Related Reports

Lupin Pharmaceuticals Inc. is voluntarily recalling four (4) lots of Quinapril Tablets to the patient (consumer/user) level due to the presence of a nitrosamine impurity, N-Nitroso-Quinapril, observed in recent testing above the Acceptable Daily Intake (ADI) level. To date, Lupin has received no reports of illness that... See More appear to relate to this issue. Lupin discontinued the marketing of Quinapril tablets in September 2022. It was distributed nationwide in the US to wholesalers, drug chains, mail-order pharmacies, and supermarkets.

Nitrosamines are common in water and foods, including cured and grilled meats, dairy products, and vegetables. Everyone is exposed to some level of nitrosamines. These impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time. Quinapril tablet USP is an angiotensin-converting enzyme (ACE) inhibitor indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.

Quinapril Tablets USP 20mg, and 40mg is packaged in 90 count bottles. The recalled lots are included in the table below:

Product: Quinapril Tablets USP, 20mg
Lot No: G102929
Expiry: 04/2023
NDC: 68180-558-09 (90’s)
UPC: 368180558095
Distribution Dates: 03/15/2021 – 09/01/2022

Product: Quinapril Tablets USP, 40mg
Lot No: G100534, G203071, G100533
Expiry: 12/2022, 12/2022, 03/2024
NDC: 68180-554-09 (90’s)
UPC: 368180554097
Distribution Dates: 03/15/2021 – 09/01/2022

Lupin Pharmaceuticals Inc. is notifying its wholesalers, distributors, drug chains, mail order pharmacies and supermarkets by phone and through recall notification and is arranging for the return of all the recalled product lots.

Patients taking, Quinapril Tablets USP, 20mg, and 40mg are advised to continue taking their medication and contact their pharmacist, physician, or medical provider for advice regarding an alternative treatment.

Wholesalers, distributors and retailers that have Quinapril Tablets USP, 20mg, and 40mg that are being recalled should discontinue distribution of the recalled product lots immediately.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Company name: Lupin Pharmaceuticals Inc.
Brand name: Lupin
Product recalled: Quinapril 20 and 40 mg tablets
Reason of the recall: Presence of nitrosamine impurity, N-Nitroso-Quinapril
FDA Recall date: December 21, 2022

Source: fda.gov
See Less
498


LV
l.....e
These thieves just sent me one of those feathered pens (dolin youpin 1502 Worlds Map Series). I reported it to my bank and now I am reporting it to the Las Vegas Police which I recommend everybody does. The bastards have a website to sell stuff, like ink for this pen , but Ill buy my ink from Office Depot. There has to be a way to shut these bastards down. Let's do it together.
Reply 2 weeks ago
Durham, North Carolina, Accord Healthcare, Inc. is voluntarily recalling a single lot of Daptomycin for Injection 500 mg/vial, and Daptomycin for Injection 350 mg/vial product contained in cartons imprinted with lot # R2200232 Exp: 01/2025 to the consumer/user level. This product is being recalled because Accord received... See More a product complaint report from a hospital pharmacy that vials labeled as “Daptomycin for Injection 500 mg/vial” were found in cartons labeled as “Daptomycin for Injection 350 mg/vial”. These products were distributed to wholesale nationwide in the USA.

The lot and expiration date printed on the outer carton and inner vial are the same and correspond to “Daptomycin for Injection 500 mg/vial.” Accordingly, Accord is voluntarily recalling all of lot #R2200232, Daptomycin for Injection 500 mg/vial, which may be in outer cartons that read “Daptomycin for Injection 500 mg/vial” OR “Daptomycin for Injection 350 mg/vial.” 

- Affected products:

Product: Daptomycin for Injection 500 mg/vial
NDC: 16729-435-05
Lot number/Expiration Date: R2200232, 01/2025

Product: Daptomycin for Injection 350 mg/vial
NDC: 16729-434-05
Lot number/Expiration Date: R2200232, 01/2025

Company name: Accord Healthcare, Inc
Brand name: Accord
Product recalled: Daptomycin for Injection
Reason of the recall: Mislabeling
FDA Recall date: December 27, 2022

Risk Statement: Administration of Daptomycin 500 mg/vial, to the population most at risk which are children or patients with renal impairment, there is a reasonable probability that the likelihood of the labeled warnings can potentially be increased if a higher than the intended dose is used which could lead to serious adverse health consequences. If these reactions occur, they may require medical treatment such as hemodialysis and systemic glucocorticoids. To date, Accord has not received any reports of adverse events related to this recall.

The product is used for the treatment of adult and pediatric patients (1 to 17 years of age) with complicated skin and skin structure infections (cSSSI) caused by susceptible isolates of the following Gram-positive bacteria: Staphylococcus aureaus (including methicillin-resistant isolates), Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus dysgalactiae subsp. equisimilis, and Enterococcus faecalis (vancomycin-susceptible isolates only).

The lot number, NDC number and expiration date of affected Daptomycin 500 mg/vial and Daptomycin 350 mg/vial product is shown below:

Product: Daptomycin for Injection 500 mg/vial
NDC: 16729-435-05
Lot number/Expiration Date: R2200232, 01/2025

Product: Daptomycin for Injection 350 mg/vial
NDC: 16729-434-05
Lot number/Expiration Date: R2200232, 01/2025

In case you experienced harm from these products, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.

Source: fda.gov
See Less
498


Pfizer company, is voluntarily recalling one lot of Vancomycin Hydrochloride Injection, USP, 1.5 g/vial Single Dose Fliptop Vial, lot 33045BA, to the user level due to two visible glass particulates observed in a single vial. The product was distributed nationwide to wholesalers/hospitals/ institutions in the United States... See More and Puerto Rico from June 23, 2022 through September 19, 2022.

If administered intravenously, patients may experience adverse events such as local irritation or swelling, vasculitis/ phlebitis, antigenic or allergic reactions, and microvascular obstruction, including pulmonary embolism. If administered orally or via a nasogastric tube, there may be the potential for gastrointestinal trauma. The risk is reduced by the possibility of detection, as the label contains a statement directing the healthcare professional to visually inspect the product for particulate matter and discoloration prior to administration.

To date, Pfizer has not received reports of any adverse events related to this recall. Vancomycin Hydrochloride is an antibiotic indicated for the treatment of serious or severe infections caused by susceptible strains of methicillin-resistant staphylococci. Vancomycin Hydrochloride is effective in the treatment of staphylococcal endocarditis, septicemia, bone infections, lower respiratory tract infections, and skin and skin-structure infections. It is used in penicillin-allergic patients, and also for patients who cannot receive or who have failed to respond to other antimicrobials, including penicillin or cephalosporin agents, and for infections caused by vancomycin-susceptible organisms that are resistant to other antimicrobials.

The NDC, Lot Number, Expiration Date, and Configuration details for Vancomycin HCl for injection, USP are indicated below.

Product: Vancomycin Injection, USP, Single-Dose Fliptop Vial
NDC: Vial: 0409-3515-11 Carton: 049-3515-01
Lot Number: 33045BA
Expiration Date: 1SEP2023
Presentation: 1.5 g/Vial
Configuration/Count: 10 units/carton, 10 cartons/case

Pfizer places the utmost emphasis on patient safety and product quality at every step in the manufacturing and supply chain process. Pfizer has notified direct consignees by letter to arrange for return of any recalled product.

Wholesalers, hospitals, institutions, and doctors with an existing inventory of the lot, which is being recalled, should discontinue use, stop distribution, and quarantine immediately. If you have further distributed the recalled product, please notify your accounts and/or any additional locations which may have received the recalled product.

In case you experienced harm from these products, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.

Company name: Hospira, Inc.
Brand name: Hospira, Inc.
Product recalled: Vancomycin Injection
Reason of the recall: Presence of Visible Glass Particulates
FDA Recall date: December 27, 2022

Source: fda.gov
See Less
498


Spectrum Laboratory Products, Inc. is voluntarily recalling three lots of Epinephrine (L-Adrenaline) USP, a bulk active pharmaceutical ingredient (API) used to manufacture or compound prescription products, to the user level. Customer complaints have found the product to be discolored. Product was distributed directly from Spectrum facilities nationwide... See More in the USA and to Canada.

Risk Statement: Epinephrine is a critical medication used during life-threatening conditions which can affect any age and any person. The use of a finished dose product manufactured or compounded with this recalled product could result in less-effective product, and incomplete treatment of life-threatening conditions including, low blood pressure, heart failure, anaphylaxis, irregular heartbeat, and heart attack. Treatment with a less-effective product, essentially underdosing epinephrine, could result in death. Spectrum Laboratory Products, Inc. has not received any reports of adverse events related to this recall.

Epinephrine (L-Adrenaline) USP bulk API Powder, is used in manufacturing and compounding of finished dose epinephrine prescription products which can be used to treat a variety of medical conditions including anaphylaxis and other severe immediate hypersensitivity reactions, asthma, bronchospasm, airway edema, nasal congestion, dilation during intraocular surgery, vasoconstrictor with local anesthetics, hypotension or shock, heart failure, bradycardia or atrioventricular block, and sudden cardiac arrest.

The Epinephrine (L-Adrenaline) USP bulk API Powder is packaged in amber glass bottles enclosed in a vacuum sealed pouch. NDC’s, Package sizes, lot numbers and expiration dates can be found in the table below. The affected Epinephrine, USP product can be identified by Spectrum catalog number EP130.

Product: Epinephrine, USP (Product code EP130)
NDC: 49452-2740-2
Package Size: 1 KG
Lot # 1KG0865
Exp Date: 31-Mar-2023

Product: Epinephrine, USP (Product code EP130)
NDC: 49452-2740-1
Package Size:100 GM
Lot # 2KL0353 / 2KF0151
Exp Date: 30-Sep-2023 / 31-Mar-2023

Product: Epinephrine, USP (Product code EP130)
NDC: 49452-2740-4
Package Size: 1 GM
Lot # 2KL0353 / 2KF0151
Exp Date: 30-Sep-2023 / 31-Mar-2023

Product: Epinephrine, USP (Product code EP130)
NDC: 49452-2740-3
Package Size: 25 GM
Lot # 2KL0353 / 2KF0151
Exp Date: 30-Sep-2023 / 31-Mar-2023

Product: Epinephrine, USP (Product code EP130)
NDC: 49452-2740-5
Package Size: 5 GM
Lot # 2KL0353 / 2KF0151
Exp Date: 30-Sep-2023 / 31-Mar-2023

Consumers, distributors, or retail pharmacies that have Epinephrine, USP catalog number EP130, which is being recalled, should stop use immediately and return to place of purchase.

In case you experienced harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance.

Company name: Spectrum Laboratory Products Inc.
Brand name: Spectrum
Product recalled: Epinephrine bulk API
Reason of the recall: Product discoloration
FDA Recall date: January 09, 2023

Source: fda.gov
See Less
498


South Amherst has canceled a boil alert for its water supply. Water is now safe to drink and use for cooking without boiling first.

Source: chroniclet.com
Published: 2022-06-03 See Less
1.2K


The Village of South Amherst is under a boil alert until further notice. Authorities advise residents to boil water for at least three minutes, don't use water from refrigerated lines or use ice from automated ice machines.

Source: twitter.com
Published: 2022-06-01 See Less
1.2K


I recieved a ring from GRA Moissante, that I did not order. I have checked all my cc's & so far have not been charged. Don't really know what to do. I even had to pay $5.40 postage to get it. I did not order this !!!! Any suggestions ? See Less


Ordered Christmas decorations got Ear muffs!.
mrsgreen.store
This web the web site I ordered from. See Less
1.9K


JE
j.......9
Yes I got ear muffs to..I just got an email back from where I ordered my ellecrib they are blaming the error on the supplier...In which they want me to mail the ear muffs back to them...Which Im to pay shipping...or give them to a friend and they will give me 45% of my money back...I said NO they should send me a shipping label and refund my money....
Reply 6 hours ago
Sunglasses
I received sunglasses that I absolutely did not order for 163.00 dollars and I am not paying for them See Less
321


Last 30 days